Fas-fas ligancl system in silicosis patients

Japanese Journal of Hygiene

Volumn 55, Issue 2, 2000, Pages 474-480

  Ueki, Ayako ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Apoptosis; Autoimmunity; Fas fas ligand system (fas fas); Silicosis

Indexed keywords

FAS ANTIGEN;

APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; HUMAN; IMMUNOLOGY; PATHOLOGY; PHYSIOLOGY; REVIEW; SILICOSIS; T LYMPHOCYTE;

ANTIGENS, CD95; APOPTOSIS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; HUMANS; SILICOSIS; T-LYMPHOCYTES;

EID: 0034218397     PISSN: 00215082     EISSN: None     Source Type: Journal    
DOI: 10.1265/jjh.55.474     Document Type: Article

References (3)

1. Bramwell B. Diffuse sclerodermia: its frequency; its occurence in stonemasons; its treatment by fibrinolysin-elevations of temperature due to fibrinolysin injections. Ed Med J 1914 ; 12 : 387.
2. Duval E, Wyllie AH. Death and the cell. Immunol Today 1986! 7: 115-9.
3. Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. JExp Med 1989 ; 169 i 1747-56.